Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 1;51(1):153-156.
doi: 10.1097/CCM.0000000000005719. Epub 2022 Dec 15.

Lessons From a Negative Clinical Trial: Novel Immunological Targets for COVID-19 and Beyond

Kathryn M Sullivan  1 , Michael A Matthay  1   2
Affiliations

Lessons From a Negative Clinical Trial: Novel Immunological Targets for COVID-19 and Beyond

Kathryn M Sullivan et al. Crit Care Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Matthay’s institution received funding from Roche-Genentech; he received funding from Cellenkos Pharmaceutical. Dr. Sullivan has disclosed that she does not have any potential conflicts of interest.

References

    1. Wick KD, Aggarwal NR, Curley MAQ, et al. : Opportunities for improved clinical trial designs in acute respiratory distress syndrome. Lancet Respir Med. 2022; 10:916–924 - PubMed
    1. Waters M, McKinnell JA, Kalil AC, et al. . Crit Care Med 2023; 51:103–116 - PMC - PubMed
    1. Lin S, Fu J, Wang C, et al. : Inflammation elevated IL-33 originating from the lung mediates inflammation in acute lung injury. Clin Immunol. 2016; 173:32–43 - PubMed
    1. Makaremi S, Asgarzadeh A, Kianfar H, et al. : The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19. Inflamm Res. 2022; 71:923–947 - PMC - PubMed
    1. Kelsen SG, Agache IO, Soong W, et al. : Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. J Allergy Clin Immunol. 2021; 148:790–798 - PubMed